PHVS Competitors & Alternatives
Compare Pharvaris BV with similar stocks in the same industry
Biotechnology
PHVS
Main Stock$30.66
Tradestie Score
62
Market Cap
$1.55B
Analyst Upside
+88.1%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IRON
Disc Medicine, Inc. Common Stock
|
$76.00
|
$2.33B | - | 40 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$37.18
|
$2.33B | - | 45 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 47 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.64
|
$2.23B | - | 51 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.33
|
$2.22B | - | 66 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$52.58
|
$2.21B | - | 70 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$18.68
|
$2.18B | - | 71 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$12.83
|
$2.08B | - | 51 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$18.56
|
$2.02B | - | 47 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$11.65
|
$2.01B | - | 58 | Compare |
More PHVS Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry